Experienced Senior Researcher in cardiovascular pathologies (endothelial dysfunction):Publications in peer reviewed journals: https://www.ncbi.nlm.nih.gov/myncbi/christopher.foote.2/bibliography/public/Successful Drug Patent:Neuraminidase inhibition to improve glycocalyx volume and function to ameliorate cardiovascular diseases in pathologies associated with glycocalyx damage. In conjunction with the Office of Technology Advancement, University of Missouri-Columbia, U.S. Publication/Patent Number: US11684603B2, Publication Date: 2023-06-27Successful Grant Award:$1,163,962 (2021-2023) Collaborative research agreement with Evergreen LLC (Private Industry): Establishing zanamivir as a treatment for cardiovascular disease in obesity and diabetes